Latest filing published 16 Jul 2021 for Oncotelic Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anthony e. Maida III: trading record in brief
Anthony e. Maida III (senior executive) discloses dealings in 3 companies, chiefly Spectrum Pharmaceuticals Inc, ONCOSEC MEDICAL Inc and Oncotelic Therapeutics, Inc. Between 20 July 2007 and 31 March 2021, the trades on record add up to 78 filings.
On the open market, the record shows 6 purchases worth €17k and 23 sales worth €1.3M. Sales outweigh purchases by €1.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 23 share grants and 25 option exercises.
In size, the median ticket on the buying side is €824.
Most recently, on 16 July 2021, the filings show a transaction in Oncotelic Therapeutics, Inc. The latest purchase dates back some time: it was published 4,616 days ago, on 20 March 2014. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anthony e. Maida III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 938,646 sharesCommon StockSEC:0001493152-21-017107:0
- 50,000 shares@ US$6.0922.3% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-033552:0
- 42,643 shares@ US$7.7524.3% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-033552:1
- 10,738 shares@ US$10.678.3% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-024510:0
- 5,500 shares@ US$5.052.0% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-021093:0
- 5,500 shares@ US$10.003.9% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-021093:1
- 5,500 shares@ US$5.052.0% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-012593:0
- 5,500 shares@ US$11.634.6% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-012593:1
- 1,550 shares@ US$3.920.4% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-005455:0
- 1,550 shares@ US$10.371.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-005455:1
- 5,700 shares@ US$5.052.1% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-005455:2
- 5,700 shares@ US$10.374.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-005455:3
- 7,250 shares@ US$3.922.0% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-002885:0
- 7,250 shares@ US$10.005.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-19-002885:1
- 7,250 shares@ US$3.922.0% of flowCommon Stock, $0.001 par valueSEC:0001209191-18-061554:0
- 7,250 shares@ US$12.606.6% of flowCommon Stock, $0.001 par valueSEC:0001209191-18-061554:1
- 7,250 shares@ US$3.922.0% of flowCommon Stock, $0.001 par valueSEC:0001209191-18-058024:0
- 7,250 shares@ US$13.076.8% of flowCommon Stock, $0.001 par valueSEC:0001209191-18-058024:1
- 10,000 shares0Common Stock, $0.001 par valueSEC:0001209191-18-038677:0
- 15,000 shares@ US$6.906.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-17-045562:0
- 13,745 shares@ US$7.536.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-17-045562:1
- 442 shares@ US$7.530.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-17-045562:2
- 880 shares@ US$7.540.4% of flowCommon Stock, $0.001 par valueSEC:0001209191-17-042386:0
- 3,523 shares@ US$6.481.4% of flowCommon Stock, $0.001 par valueSEC:0001209191-17-040176:0
- 10,000 shares0Common Stock, $0.001 par valueSEC:0001209191-17-040176:1
25 of 77 declarations
